Core Wealth Advisors (Florida)’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-19
Closed -$5K 216
2021
Q4
$5K Buy
+19
New +$5.55K ﹤0.01% 182
2021
Q2
Sell
-31
Closed -$4K 197
2021
Q1
$4K Buy
+31
New +$4.49K ﹤0.01% 151

Other funds holding MRNA

Core Wealth Advisors (Florida)'s MRNA Position: Q1 2022 in Review

Core Wealth Advisors (Florida) sold out of Moderna (MRNA) in Q1 2022, closing a stake of 19 shares — an estimated $5K sold.

Core Wealth Advisors (Florida) first reported a position in MRNA in Q1 2021 and held it in 2 quarters. The position peaked at $5K in Q4 2021. 1,006 funds tracked by Wall St. Rank hold MRNA as of Q1 2022.

  • Core Wealth Advisors (Florida) reported no remaining Moderna position as of Q1 2022 after selling out during the quarter.
  • Core Wealth Advisors (Florida) sold 19 Moderna shares in Q1 2022, an estimated $5K.
  • Core Wealth Advisors (Florida) first reported a position in Moderna in Q1 2021 and held it in 2 quarters.
  • Core Wealth Advisors (Florida)'s Moderna position peaked at $5K in Q4 2021.
  • 1,006 funds tracked by Wall St. Rank held Moderna as of Q1 2022.

Based on Core Wealth Advisors (Florida)'s 13F filing for Q1 2022, filed 16 May 2022.